Litigation for OSIMERTINIB MESYLATE
✉ Email this page to a colleague
US Court Litigation for OSIMERTINIB MESYLATE
Patent | Case Name | Docket | Date Filed | Date Terminated | Cause | Court | Jury Demand | Link To Docket |
---|---|---|---|---|---|---|---|---|
10,183,020 | ⤷ Sign Up | ⤷ Sign Up | 2020-02-11 | 2022-04-25 | 35:1 Patent Infringement | District Court, D. Delaware | None | ⤷ Sign Up |
10,183,020 | ⤷ Sign Up | ⤷ Sign Up | 2021-04-16 | 2021-11-15 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Sign Up |
10,183,020 | ⤷ Sign Up | ⤷ Sign Up | 2021-07-02 | 2022-04-25 | 35:271 Patent Infringement | District Court, D. Delaware | None | ⤷ Sign Up |
8,946,235 | Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP | ⤷ Sign Up | 2021-09-22 | 2024-08-14 | 35:1 Patent Infringement | District Court, D. Delaware | Plaintiff | ⤷ Sign Up |
9,732,058 | Puma Biotechnology, Inc. v. AstraZeneca Pharmaceuticals LP | ⤷ Sign Up | 2021-09-22 | 2024-08-14 | 35:1 Patent Infringement | District Court, D. Delaware | Plaintiff | ⤷ Sign Up |
>Patent | >Case Name | >Docket | >Date Filed | >Date Terminated | >Cause | >Court | >Jury Demand | >Link To Docket |